Trial intelligence / Profile preview

PK of Venofer in Pediatric NDD-CKD

NCT00721188Phase 2Completed

Sponsor
American Regent, Inc.
Start
Jan 2006
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of iron sucrose in anemia, sponsored by American Regent, Inc. Primary endpoints: Maximum Observed Serum Concentration at 12 hours, Time to Maximum Serum Concentration at 12 hours and 4 more. Started Jan 2006; status: completed.

02

Drugs

iron sucrose
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00721188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00721188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call